First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis

NCT00875446 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: PLACEBO
DRUG: GSK1223249

Sponsor

GlaxoSmithKline